Back to overview
Sabine Linn group
Dr. Sabine Linn is a professor of translational oncology
focusing on breast cancer at Utrecht University, The Netherlands.
Linn received her medical degree (1991, cum laude) at the State
University Leiden, The Netherlands, and her internal medicine board
certification (2000) at the University Medical Center Utrecht, The
Netherlands. She earned her PhD (1998) on the subject of multidrug
resistance in solid tumors from the Free University of Amsterdam
under supervision of prof. Dr H.M. Pinedo.
She was awarded a Dutch Cancer Society Research Fellowship in
2000 and developed two conditional knock-out mouse models, one for
non-small cell lung cancer and one for small cell lung cancer,
respectively, in close collaboration with Dr Ralph Meuwissen in the
laboratory of prof. Dr A.J. Berns at the Netherlands Cancer
Institute, Amsterdam, The Netherlands. From 2001 to 2002 she was a
postdoctoral research fellow in the laboratories of prof. Dr P.O.
Brown, and prof. Dr M. van de Rijn, at Stanford University Medical
School, Stanford, CA, where she contributed to the development of a
molecular classification for soft tissue sarcomas. She returned to
the Netherlands Cancer Institute in Amsterdam, where she earned her
medical oncology certification (2002-2005) and became a senior
staff member of the Division of Medical Oncology (2003).
Since 2005 she has also been a group leader at the Division of
Molecular Pathology at the Netherlands Cancer Institute where she
and her research group focus on the molecular dissection of breast
cancer by differential drug sensitivity. To further develop this
research line Dr. Linn was awarded a Dutch Cancer Society Clinical
Research Award in 2006. From 2008-2012, Dr Linn served as chair of
the Working Group on (neo)adjuvant systemic therapy of the Dutch
Breast Cancer Trialists' Group (BOOG).